Eskayef

Eskayef specialises in contract manufacturing and product development of oral, injectable and topical dosage forms of generic and cephalosporin products. Eskayef’s current portfolio includes a range of 300 brands in 53 therapeutic areas. Product development of patented molecules is a key activity for Eskayef. The company’s cGMP facilities manufacture dosage forms, from oral solid dose to sterile products, and include a dedicated cephalosporin facility.

The company is approved by the UK MHRA for the manufacture of a wide range of dosage forms and all its facilities / manufacturing plants were designed and are operated within cGMP regulations.

Contract manufacture of oral, injectable and topical dosage forms

Eskayef’s core services are:

• Contract manufacture of brand pharmaceuticals
• Pharmaceutical development, manufacture, production and packaging
• Solid and liquid oral dosage form manufacture
• Formulation, mixing and packaging of pharmaceutical powders and liquids
• QC analysis, QC release, product development and stability studies
• Contract manufacture of oral liquid and topical healthcare products
• Fill / finish production capabilities
• Parenteral manufacturing services
• Pharmaceutical suspensions and freeze-dried dosage forms development

Sterile products and oral solid dosage form manufacturing facilities

Eskayef’s manufacturing areas comply with the latest EU Annex 1 requirements for sterile products, and the oral solid dosage form facilities are designed to ISO 8 standards. Validation of the facilities and installed equipment has been carried out in accordance with EU Annex 15 to ensure consistent performance and reliability of the equipment and the manufacturing processes.